Rajani Kanteti

Department of Medicine, University of Chicago

Affiliated withUniversity of Chicago

Research Area

Biography

Rajani Kanteti has not added Biography.
If you are Rajani Kanteti and would like to personalize this page please email our Author Liaison for assistance.

JoVE Journal Publications

ArticleTotal : 1	Year
Publication title Cited by 5	2011

Other Publications

Article	Year
Enteropathogenic Escherichia coli EspG disrupts microtubules and in conjunction with Orf3 enhances perturbation of the tight junction barrier. Molecular microbiology\| PubMed ID: 15813736	2005
Balance of bacterial pro- and anti-inflammatory mediators dictates net effect of enteropathogenic Escherichia coli on intestinal epithelial cells. American journal of physiology. Gastrointestinal and liver physiology\| PubMed ID: 16322091	2006
Paxillin is a target for somatic mutations in lung cancer: implications for cell growth and invasion. Cancer research\| PubMed ID: 18172305	2008
PAX5 is expressed in small-cell lung cancer and positively regulates c-Met transcription. Laboratory investigation; a journal of technical methods and pathology\| PubMed ID: 19139719	2009
The MET receptor tyrosine kinase is a potential novel therapeutic target for head and neck squamous cell carcinoma. Cancer research\| PubMed ID: 19318576	2009
Enterohemorrhagic Escherichia coli suppresses inflammatory response to cytokines and its own toxin. American journal of physiology. Gastrointestinal and liver physiology\| PubMed ID: 19556613	2009
Ethnic differences and functional analysis of MET mutations in lung cancer. Clinical cancer research : an official journal of the American Association for Cancer Research\| PubMed ID: 19723643	2009
MET, HGF, EGFR, and PXN gene copy number in lung cancer using DNA extracts from FFPE archival samples and prognostic significance. Journal of environmental pathology, toxicology and oncology : official organ of the International Society for Environmental Toxicology and Cancer\| PubMed ID: 19817696	2009
CBL is frequently altered in lung cancers: its relationship to mutations in MET and EGFR tyrosine kinases. PloS one\| PubMed ID: 20126411	2010
EphA2 mutation in lung squamous cell carcinoma promotes increased cell survival, cell invasion, focal adhesions, and mammalian target of rapamycin activation. The Journal of biological chemistry\| PubMed ID: 20360610	2010
Functional EGFR germline polymorphisms may confer risk for EGFR somatic mutations in non-small cell lung cancer, with a predominant effect on exon 19 microdeletions. Cancer research\| PubMed ID: 21292812	2011
Role of protein kinase C Î² and vascular endothelial growth factor receptor in malignant pleural mesothelioma: Therapeutic implications and the usefulness of Caenorhabditis elegans model org... Journal of carcinogenesis\| PubMed ID: 21383961	2011
RON (MST1R) is a novel prognostic marker and therapeutic target for gastroesophageal adenocarcinoma. Cancer biology & therapy\| PubMed ID: 21543897	2011
Proteomic characterization of non-small cell lung cancer in a comprehensive translational thoracic oncology database. Journal of clinical bioinformatics\| PubMed ID: 21603121	2011
Characterization of NOL7 gene point mutations, promoter methylation, and protein expression in cervical cancer. International journal of gynecological pathology : official journal of the International Society of Gynecological Pathologists\| PubMed ID: 22123719	2012